Citations (56)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (3)
Joseph Mermelstein, Alanna Chait Mermelstein & Maxwell M Chait. (2016) Proton pump inhibitors for the treatment of patients with erosive esophagitis and gastroesophageal reflux disease: current evidence and safety of dexlansoprazole. Clinical and Experimental Gastroenterology 9, pages 163-172.
Read now
Read now
David Peura, Anne Le Moigne, Charles Pollack, Peter Nagy & Tore Lind. (2016) A 14-day regimen of esomeprazole 20 mg/day for frequent heartburn: durability of effects, symptomatic rebound, and treatment satisfaction. Postgraduate Medicine 128:6, pages 577-583.
Read now
Read now
Harohalli Shashidhar & Vasundhara Tolia. (2013) Esophagitis in children: an update on current pharmacotherapy. Expert Opinion on Pharmacotherapy 14:18, pages 2475-2487.
Read now
Read now
Articles from other publishers (53)
Diane Heels-Ansdell, Laurent Billot, Lehana Thabane, Waleed Alhazzani, Adam Deane, Gordon Guyatt, Simon Finfer, François Lauzier, John Myburgh, Paul Young, Yaseen Arabi, John Marshall, Shane English, John Muscedere, Marlies Ostermann, Bala Venkatesh, Nicole Zytaruk, Miranda Hardie, Naomi Hammond, Serena Knowles, Lois Saunders, Alexis Poole, Abdulrahman Al-Fares, Feng Xie, Richard Hall & Deborah Cook. (2023) REVISE: re-evaluating the inhibition of stress erosions in the ICU—statistical analysis plan for a randomized trial. Trials 24:1.
Crossref
Crossref
Danny Jenkins & Ines Modolell. (2023) Proton pump inhibitors. BMJ, pages e070752.
Crossref
Crossref
L. Veremme, A. Baudouin, A. Janoly-Dumenil & B. Charpiat. (2023) Thésaurus d’interventions pharmaceutiques associées aux prescriptions injustifiées d’inhibiteurs de la pompe à protons. Annales Pharmaceutiques Françaises 81:3, pages 552-567.
Crossref
Crossref
Rebecca Field & Hilary Field. (2023) Barriers to deprescribing proton pump inhibitors and how to overcome them. Gastrointestinal Nursing 21:3, pages 22-28.
Crossref
Crossref
Malte H. Wehmeyer, Thomas Horvatits, Anika Buchholz, Linda Krause, Sarah Walter, Antonia Zapf, Ansgar W. Lohse & Johannes Kluwe. (2022) Stop of proton-pump inhibitor treatment in patients with liver cirrhosis (STOPPIT): study protocol for a prospective, multicentre, controlled, randomized, double-blind trial. Trials 23:1.
Crossref
Crossref
Barbara Farrell, Elliot Lass, Paul Moayyedi, Deanna Ward & Wade Thompson. (2022) Reduce unnecessary use of proton pump inhibitors. BMJ, pages e069211.
Crossref
Crossref
Carlo Caiati, Adriana Argentiero, Stefano Favale & Mario Erminio Lepera. (2022) Cardiorenal Syndrome Triggered by Slowly Progressive Drugs Toxicity-Induced
Renal Failure along with Minimal Mitral Disease: A Case Report. Endocrine, Metabolic & Immune Disorders - Drug Targets 22:9, pages 970-977.
Crossref
Crossref
Adesola Odunayo, Gina Galyon, Joshua Price, Silke Hecht & M. Katherine Tolbert. (2022) Evaluation of a long‐acting injectable formulation of omeprazole in healthy dogs. Journal of Veterinary Internal Medicine 36:4, pages 1416-1421.
Crossref
Crossref
Decio CHINZON, Gerson DOMINGUES, Nivia TOSETTO & Marcos PERROTTI. (2022) SAFETY OF LONG-TERM PROTON PUMP INHIBITORS: FACTS AND MYTHS. Arquivos de Gastroenterologia 59:2, pages 219-225.
Crossref
Crossref
Monthira Maneerattanaporn, Rapat Pittayanon, Tanisa Patcharatrakul, Chalermrat Bunchorntavakul, Siam Sirinthornpanya, Panyavee Pitisuttithum, Asawin Sudcharoen, Uayporn Kaosombatwattana, Kawin Tangvoraphongchai, Reawika Chaikomin, Kamin Harinwan, Karjpong Techathuvanan, Sawangpong Jandee, Phuripong Kijdamrongthum, Anupong Tangaroonsanti, Kulthep Rattanakovit, Sakkarin Chirapongsathorn, Sutep Gonlachanvit, Surapol Surangsrirat, Duangporn Werawatganon, Kitti Chunlertrith, Varocha Mahachai, Somchai Leelakusolvong & Wanich Piyanirun. (2022) Thailand guideline 2020 for medical management of gastroesophageal reflux disease. Journal of Gastroenterology and Hepatology 37:4, pages 632-643.
Crossref
Crossref
Jasmine Giani, Carole R Chambers & Michael B Sawyer. (2021) Case report: Proton pump inhibitor drug-related problem in pancreatic cancer patient unmasks pancreatic enzyme insufficiency. Journal of Oncology Pharmacy Practice 28:2, pages 457-461.
Crossref
Crossref
Johannes Heimbucher & Stephan M. Freys. 2022. Allgemein- und Viszeralchirurgie II. Allgemein- und Viszeralchirurgie II
143
159
.
Emily Hendricks, Aman N Ajmeri, Monider M Singh, Milliejoan Mongalo & Lynne J Goebel. (2021) A Randomized Open-Label Study of Two Methods of Proton Pump Inhibitors Discontinuation. Cureus.
Crossref
Crossref
Rita Baptista, Ryane Englar, Berta São Braz & Rodolfo Leal. (2021) Survey-Based Analysis of Current Trends for Prescribing Gastrointestinal Protectants among Small-Animal General Practitioners in Portugal. Veterinary Sciences 8:5, pages 70.
Crossref
Crossref
Valeria Atenea Costa, Oscar Mariano Pinto Saavedra, Albis Cecilia Hani Amador, Ana María Leguízamo Naranjo & Andrés Felipe Ardila Hani. (2021) Actualización en la interpretación de la medición del pH e impedanciometría. Revista colombiana de Gastroenterología 36:1, pages 73-80.
Crossref
Crossref
Baptiste Gramont, Laurent Bertoletti, Michel Roy, Xavier Roblin, Bernard Tardy & Pascal Cathébras. (2020) Utilisation et gestion des inhibiteurs de la pompe à protons : une étude observationnelle. Therapies 75:6, pages 649-662.
Crossref
Crossref
Olubode A. Olufajo, Amanda Wilson, Bruke Yehayes, Ahmad Zeineddin, Edward E. Cornwell & Mallory Williams. (2020) Trends in the Surgical Management and Outcomes of Complicated Peptic Ulcer Disease. The American Surgeon 86:7, pages 856-864.
Crossref
Crossref
Anja Rieckert, Annette Becker, Norbert Donner-Banzhof, Annika Viniol, Bettina Bücker, Stefan Wilm, Andreas Sönnichsen & Anne Barzel. (2019) Reduction of the long-term use of proton pump inhibitors by a patient-oriented electronic decision support tool (arriba-PPI): study protocol for a randomized controlled trial. Trials 20:1.
Crossref
Crossref
Dorte E Jarbøl, Jesper Lykkegaard, Jane M Hansen, Anders Munck & Peter F Haastrup. (2019) Prescribing of proton-pump inhibitors: auditing the management and reasons for prescribing in Danish general practice. Family Practice 36:6, pages 758-764.
Crossref
Crossref
Naldy Parodi López & Susanna Maria Wallerstedt. (2019) Quality of prescribing in older people from a broad family physician perspective: a descriptive pilot study. BMJ Open 9:6, pages e027290.
Crossref
Crossref
Shuichi Miyamoto, Momoko Tsuda, Mototsugu Kato, Katsuhiro Mabe, Shuichi Muto, Shoko Ono, Yuichi Shimizu & Naoya Sakamoto. (2019) Evaluation of gastric acid suppression with vonoprazan using calcium carbonate breath test. Journal of Clinical Biochemistry and Nutrition 64:2, pages 174-179.
Crossref
Crossref
Ewa Kaczmar, Andrzej Rychlik & Marta Szweda. (2018) The evaluation of three treatment protocols using oral prednisone and oral meloxicam for therapy of canine idiopathic lymphoplasmacytic rhinitis: a pilot study. Irish Veterinary Journal 71:1.
Crossref
Crossref
David A. Peura, Anne Le Moigne, Heather Wassel & Charles Pollack. (2018) Sustained efficacy following resolution of frequent heartburn with an over-the-counter regimen of esomeprazole 20 mg or placebo for 14 days: two randomized trials. BMC Gastroenterology 18:1.
Crossref
Crossref
Muhammad Miftahussurur, Dalla Doohan, Iswan Abbas Nusi, Pangestu Adi, Yudith Annisa Ayu Rezkitha, Langgeng Agung Waskito, Kartika Afrida Fauzia, Taufan Bramantoro, Ummi Maimunah, Husin Thamrin, Safitri Indah Masithah, Sukadiono Sukadiono, Tomohisa Uchida, Maria Inge Lusida & Yoshio Yamaoka. (2018) Gastroesophageal reflux disease in an area with low Helicobacter pylori infection prevalence. PLOS ONE 13:11, pages e0205644.
Crossref
Crossref
Peter Bytzer. (2018) Deprescribing proton pump inhibitors: why, when and how. Medical Journal of Australia 209:10, pages 436-438.
Crossref
Crossref
Vincenzo Savarino, Elisa Marabotto, Patrizia Zentilin, Manuele Furnari, Giorgia Bodini, Costanza De Maria, Gaia Pellegatta, Claudia Coppo & Edoardo Savarino. (2018) The appropriate use of proton-pump inhibitors. Minerva Medica 109:5.
Crossref
Crossref
Vincenzo Savarino, Cesare Tosetti, Edoardo Benedetto, Debora Compare & Gerardo Nardone. (2018) Appropriateness in prescribing PPIs: A position paper of the Italian Society of Gastroenterology (SIGE) — Study section “Digestive Diseases in Primary Care”. Digestive and Liver Disease 50:9, pages 894-902.
Crossref
Crossref
Peter Fentz Haastrup, Wade Thompson, Jens Søndergaard & Dorte Ejg Jarbøl. (2018) Side Effects of Long-Term Proton Pump Inhibitor Use: A Review. Basic & Clinical Pharmacology & Toxicology 123:2, pages 114-121.
Crossref
Crossref
Anne M Rowat, Catriona Graham & Martin Dennis. (2018) Diagnostic accuracy of a pH stick, modified to detect gastric lipase, to confirm the correct placement of nasogastric tubes. BMJ Open Gastroenterology 5:1, pages e000218.
Crossref
Crossref
Anne M Rowat, Catriona Graham & Martin Dennis. (2018) Study to determine the likely accuracy of pH testing to confirm nasogastric tube placement. BMJ Open Gastroenterology 5:1, pages e000211.
Crossref
Crossref
Michaël Rochoy, Sébastien Dubois, Raymond Glantenet, Sophie Gautier & Marc Lambert. (2018) Le rebond d’acidité gastrique après arrêt d’un inhibiteur de la pompe à protons : revue narrative de littérature. Therapies 73:3, pages 237-246.
Crossref
Crossref
Pauline De Bruyne & Shinya Ito. (2017) Toxicity of long-term use of proton pump inhibitors in children. Archives of Disease in Childhood 103:1, pages 78-82.
Crossref
Crossref
Carmelo Scarpignato & Luigi Gatta. 2018. Reflux Aspiration and Lung Disease. Reflux Aspiration and Lung Disease
269
291
.
. (2017) Prescribing PPIs. Drug and Therapeutics Bulletin 55:10, pages 117-120.
Crossref
Crossref
R. Schey, S.P. Alla, D. Midani & H.P. Parkman. (2017) Gastroesophageal reflux disease-related symptom recurrence in patients discontinuing proton pump inhibitors for Bravo wireless esophageal pH monitoring study. Revista de Gastroenterología de México (English Edition) 82:4, pages 277-286.
Crossref
Crossref
R. Schey, S.P. Alla, D. Midani & H.P. Parkman. (2017) Recurrencia sintomática relacionada con la enfermedad por reflujo gastroesofágico en pacientes que descontinúan los inhibidores de la bomba de protones durante el estudio inalámbrico de monitorización de pH esofágico Bravo ®. Revista de Gastroenterología de México 82:4, pages 277-286.
Crossref
Crossref
A. López-Colombo, M.S. Pacio-Quiterio, L.Y. Jesús-Mejenes, J.E.G. Rodríguez-Aguilar, M. López-Guevara, A.J. Montiel-Jarquín, J.C. López-Alvarenga, E.R. Morales-Hernández, V.R. Ortiz-Juárez & L. Ávila-Jiménez. (2017) Risk factors associated with gastroesophageal reflux disease relapse in primary care patients successfully treated with a proton pump inhibitor. Revista de Gastroenterología de México (English Edition) 82:2, pages 106-114.
Crossref
Crossref
A. López-Colombo, M.S. Pacio-Quiterio, L.Y. Jesús-Mejenes, J.E.G. Rodríguez-Aguilar, M. López-Guevara, A.J. Montiel-Jarquín, J.C. López-Alvarenga, E.R. Morales-Hernández, V.R. Ortiz-Juárez & L. Ávila-Jiménez. (2017) Factores de riesgo asociados a recaída de enfermedad por reflujo gastroesofágico en pacientes de primer nivel de atención exitosamente tratados con inhibidor de la bomba de protones. Revista de Gastroenterología de México 82:2, pages 106-114.
Crossref
Crossref
Tom D. Wilsdon, Ivanka Hendrix, Tilenka R. J. Thynne & Arduino A. Mangoni. (2017) Effectiveness of Interventions to Deprescribe Inappropriate Proton Pump Inhibitors in Older Adults. Drugs & Aging 34:4, pages 265-287.
Crossref
Crossref
Evence DaureLinda RossCynthia R. L. Webster. (2017) Gastroduodenal Ulceration in Small Animals: Part 2. Proton Pump Inhibitors and Histamine-2 Receptor Antagonists. Journal of the American Animal Hospital Association 53:1, pages 11-23.
Crossref
Crossref
Carmelo Scarpignato, Luigi Gatta, Angelo Zullo & Corrado Blandizzi. (2016) Effective and safe proton pump inhibitor therapy in acid-related diseases – A position paper addressing benefits and potential harms of acid suppression. BMC Medicine 14:1.
Crossref
Crossref
Anton Pottegård, Anne Broe, Jesper Hallas, Ove B. Schaffalitzky de Muckadell, Annmarie T. Lassen & Anders B. Lødrup. (2016) Use of proton-pump inhibitors among adults: a Danish nationwide drug utilization study. Therapeutic Advances in Gastroenterology 9:5, pages 671-678.
Crossref
Crossref
Fatmah Othman, Timothy R. Card & Colin J. Crooks. (2016) Proton pump inhibitor prescribing patterns in the UK: a primary care database study. Pharmacoepidemiology and Drug Safety 25:9, pages 1079-1087.
Crossref
Crossref
P. F. Haastrup, M. S. Paulsen, R. D. Christensen, J. Søndergaard, J. M. Hansen & D. E. Jarbøl. (2016) Medical and non-medical predictors of initiating long-term use of proton pump inhibitors: a nationwide cohort study of first-time users during a 10-year period. Alimentary Pharmacology & Therapeutics 44:1, pages 78-87.
Crossref
Crossref
Christopher M. Stark & Cade M. Nylund. (2016) Side Effects and Complications of Proton Pump Inhibitors: A Pediatric Perspective. The Journal of Pediatrics 168, pages 16-22.
Crossref
Crossref
L. Sauvaget, L. Rolland, S. Dabadie, J. Desblaches, N. Bernard, M.-A. Vandenhende, F. Bonnet, S. Pédeboscq & P. Morlat. (2015) Rapport sur l’utilisation des inhibiteurs de la pompe à protons : les recommandations françaises sont-elles respectées ?. La Revue de Médecine Interne 36:10, pages 651-657.
Crossref
Crossref
Jon Eik Zwisler, Dorte Ejg Jarbøl, Annmarie Touborg Lassen, Jakob Kragstrup, Niels Thorsgaard & Ove B. Schaffalitzky de Muckadell. (2015) Placebo-Controlled Discontinuation of Long-Term Acid-Suppressant Therapy: A Randomised Trial in General Practice. International Journal of Family Medicine 2015, pages 1-7.
Crossref
Crossref
Ping-I Hsu, Ching-Liang Lu, Deng-Chyang Wu, Chao-Hung Kuo, Sung-Shuo Kao, Chun-Chao Chang, Wei-Chen Tai, Kwok-Hung Lai, Wen-Chih Chen, Huay-Min Wang, Jin-Shiung Cheng, Tzung-Jiun Tsai & Seng-Kee Chuah. (2015) Eight Weeks of Esomeprazole Therapy Reduces Symptom Relapse, Compared With 4 Weeks, in Patients With Los Angeles Grade A or B Erosive Esophagitis. Clinical Gastroenterology and Hepatology 13:5, pages 859-866.e1.
Crossref
Crossref
Maryann Mazer-Amirshahi, Peter M. Mullins, John van den Anker, Andrew Meltzer & Jesse M. Pines. (2014) Rising rates of proton pump inhibitor prescribing in US emergency departments. The American Journal of Emergency Medicine 32:6, pages 618-622.
Crossref
Crossref
Chuan Tian, Lixin Zhu, Dan Yu, Zhiwei Cao, Tingguo Kang & Ruixin Zhu. (2014) The Stereoselectivity of CYP2C19 on R- and S-isomers of Proton Pump Inhibitors. Chemical Biology & Drug Design 83:5, pages 610-621.
Crossref
Crossref
Dustin A. Carlson & John E. Pandolfino. (2014) Acid and Nonacid Reflux Monitoring. Gastroenterology Clinics of North America 43:1, pages 89-104.
Crossref
Crossref
Hólmfridur Helgadóttir, David C. Metz, Yu-Xiao Yang, Andrew D. Rhim & Einar S. Björnsson. (2014) The effects of long-term therapy with proton pump inhibitors on meal stimulated gastrin. Digestive and Liver Disease 46:2, pages 125-130.
Crossref
Crossref
Ann Marie Hart. (2013) Evidence-based recommendations for GERD treatment. The Nurse Practitioner 38:8, pages 26-34.
Crossref
Crossref